Equity

BGF World Healthscience Fund

Overview

Important Information: Capital at Risk. The value of investments and the income from them can fall as well as rise and are not guaranteed. Investors may not get back the amount originally invested. Investment risk is concentrated in specific sectors, countries, currencies or companies. This means the Fund is more sensitive to any localised economic, market, political, sustainability-related or regulatory events. The value of equities and equity-related securities can be affected by daily stock market movements. Other influential factors include political, economic news, company earnings and significant corporate events. Active management of currency exposure through derivatives may make the Fund more sensitive to changes in foreign exchange rates. If the currency exposures against which the Fund is hedged appreciates investors may not benefit from such appreciation. The Fund seeks to exclude companies engaging in certain activities inconsistent with ESG criteria. Investors should therefore make a personal ethical assessment of the Fund’s ESG screening prior to investing in the Fund. Such ESG screening may adversely affect the value of the Fund’s investments compared to a fund without such screening.
Loading

Performance

Performance

Growth of Hypothetical 10,000

Performance chart data not available for display.
View full chart

Reinvestments

This fund does not have any distributions data as of now.
  From
30-Jun-2017
To
30-Jun-2018
From
30-Jun-2018
To
30-Jun-2019
From
30-Jun-2019
To
30-Jun-2020
From
30-Jun-2020
To
30-Jun-2021
From
30-Jun-2021
To
30-Jun-2022
Total Return (%)

as of Jun 30, 2022

5.47 13.74 16.11 15.68 7.60
  1Y 3Y 5Y 10y Incept.
5.63 12.01 12.96 15.17 8.11
  YTD 1m 3M 1Y 3Y 5Y 10y Incept.
0.03 -2.79 2.65 5.63 40.54 83.95 310.60 430.91
The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.

Key Facts

Key Facts

Size of Fund (Millions) as of Sep 30, 2022 USD 13,363.340
12m Trailing Yield -
Number of Holdings as of Aug 31, 2022 94
Base Currency U.S. Dollar
Fund Inception Date Apr 6, 2001
Share Class Inception Date Apr 6, 2001
Asset Class Equity
Morningstar Category Sector Equity Healthcare
SFDR Classification Article 8
Domicile Luxembourg
Regulatory Structure UCITS
Management Company BlackRock (Luxembourg) S.A.
Ongoing Charge 1.78%
ISIN LU0171307068
Bloomberg Ticker MERHLEA
Annual Management Fee 1.50%
Initial Charge 5.00%
Performance Fee 0.00%
SEDOL 7091115
Dealing Settlement Trade Date + 3 days
Dealing Frequency Daily, forward pricing basis
Minimum Initial Investment EUR 5000
Minimum Subsequent Investment -
Use of Income Accumulating

Sustainability Characteristics

Sustainability Characteristics

Sustainability Characteristics provide investors with specific non-traditional metrics. Alongside other metrics and information, these enable investors to evaluate funds on certain environmental, social and governance characteristics. Sustainability Characteristics do not provide an indication of current or future performance nor do they represent the potential risk and reward profile of a fund. They are provided for transparency and for information purposes only. Sustainability Characteristics should not be considered solely or in isolation, but instead are one type of information that investors may wish to consider when assessing a fund.


The metrics are not indicative of how or whether ESG factors will be integrated into a fund. Unless otherwise stated in fund documentation and included within a fund’s investment objective, the metrics do not change a fund’s investment objective or constrain the fund’s investable universe, and there is no indication that an ESG or Impact focused investment strategy or exclusionary screens will be adopted by a fund. For more information regarding a fund's investment strategy, please see the fund's prospectus.


Review the MSCI methodologies behind Sustainability Characteristics using the links below.

MSCI ESG Fund Rating (AAA-CCC) as of Sep 21, 2022 AAA
MSCI ESG % Coverage as of Sep 21, 2022 98.46
MSCI ESG Quality Score (0-10) as of Sep 21, 2022 9.96
MSCI ESG Quality Score - Peer Percentile as of Sep 21, 2022 93.27
Fund Lipper Global Classification as of Sep 21, 2022 Equity Sector Healthcare
Funds in Peer Group as of Sep 21, 2022 446
MSCI Weighted Average Carbon Intensity (Tons CO2E/$M SALES) as of Sep 21, 2022 14.18
MSCI Weighted Average Carbon Intensity % Coverage as of Sep 21, 2022 96.59
All data is from MSCI ESG Fund Ratings as of Sep 21, 2022, based on holdings as of Apr 30, 2022. As such, the fund’s sustainable characteristics may differ from MSCI ESG Fund Ratings from time to time.

To be included in MSCI ESG Fund Ratings, 65% of the fund’s gross weight must come from securities with ESG coverage by MSCI ESG Research (certain cash positions and other asset types deemed not relevant for ESG analysis by MSCI are removed prior to calculating a fund’s gross weight; the absolute values of short positions are included but treated as uncovered), the fund’s holdings date must be less than one year old, and the fund must have at least ten securities. For newly launched funds, Sustainability Characteristics are typically available 6 months after launch.

Business Involvement

Business Involvement

Business Involvement metrics can help investors gain a more comprehensive view of specific activities in which a fund may be exposed through its investments.


Business Involvement metrics are not indicative of a fund’s investment objective, and, unless otherwise stated in fund documentation and included within a fund’s investment objective, do not change a fund’s investment objective or constrain the fund’s investable universe, and there is no indication that an ESG or Impact focused investment strategy or exclusionary screens will be adopted by a fund. For more information regarding a fund's investment strategy, please see the fund's prospectus.


Review the MSCI methodology behind the Business Involvement metrics, using links below.

MSCI - Controversial Weapons as of Aug 31, 2022 0.00%
MSCI - UN Global Compact Violators as of Aug 31, 2022 0.00%
MSCI - Nuclear Weapons as of Aug 31, 2022 0.00%
MSCI - Thermal Coal as of Aug 31, 2022 0.00%
MSCI - Civilian Firearms as of Aug 31, 2022 0.00%
MSCI - Oil Sands as of Aug 31, 2022 0.00%
MSCI - Tobacco as of Aug 31, 2022 0.00%

Business Involvement Coverage as of Aug 31, 2022 99.72%
Percentage of Fund not covered as of Aug 31, 2022 0.34%
BlackRock business involvement exposures as shown above for Thermal Coal and Oil Sands are calculated and reported for companies that generate more than 5% of revenue from thermal coal or oil sands as defined by MSCI ESG Research. For the exposure to companies that generate any revenue from thermal coal or oil sands (at a 0% revenue threshold), as defined by MSCI ESG Research, it is as follows: Thermal Coal 0.00% and for Oil Sands 0.00%.

Business Involvement metrics are calculated by BlackRock using data from MSCI ESG Research which provides a profile of each company’s specific business involvement. BlackRock leverages this data to provide a summed up view across holdings and translates it to a fund's market value exposure to the listed Business Involvement areas above.


Business Involvement metrics are designed only to identify companies where MSCI has conducted research and identified as having involvement in the covered activity. As a result, it is possible there is additional involvement in these covered activities where MSCI does not have coverage. This information should not be used to produce comprehensive lists of companies without involvement. Business Involvement metrics are only displayed if at least 1% of the fund’s gross weight includes securities covered by MSCI ESG Research.

ESG Integration

ESG Integration

ESG integration is the practice of incorporating material environmental, social and governance (ESG) information or insights alongside traditional measures into the investment decision process to improve long term financial outcomes of portfolios. Unless otherwise stated in Fund documentation or included within the Fund’s investment objective, inclusion of this statement does not imply that the Fund has an ESG-aligned investment objective, but rather describes how ESG information is considered as part of the overall investment process.


The Fund manager includes ESG considerations in combination with other information in the research and decision phases of the investment process. The Fund manager conducts regular portfolio reviews between with the Risk and Quantitative Analysis group and with the Chief Investment Officers. These reviews include discussion of the portfolio’s exposure to material ESG risks, as well as exposure to sustainability-related business involvements, climate-related metrics, and other factors.

Ratings

Ratings

Morningstar Rating

5 stars
Overall Morningstar Rating for BGF World Healthscience Fund, Class A2, as of Sep 30, 2022 rated against 435 Sector Equity Healthcare Funds.

Risk Indicator

Risk Indicator

1
2
3
4
5
6
7
Low Risk High Risk
Low Yield High Yield

Holdings

Holdings

as of Aug 31, 2022
Name Weight (%)
UNITEDHEALTH GROUP INC 8.96
JOHNSON & JOHNSON 6.05
ASTRAZENECA PLC 4.89
ELI LILLY 3.84
PFIZER INC 3.47
Name Weight (%)
ROCHE HOLDING PAR AG 3.33
THERMO FISHER SCIENTIFIC INC 3.29
MERCK & CO INC 3.21
ABBOTT LABORATORIES 3.05
ABBVIE INC 3.03
Holdings subject to change

Pricing & Exchange

Pricing & Exchange

Investor Class Currency Distribution Frequency NAV NAV Amount Change NAV % Change 52wk High 52wk Low Bid Price ISIN Offer Price TIS
A2 EUR Accumulating 58.61 0.14 0.24 62.03 53.29 - LU0171307068 - -
X2 USD Accumulating 71.87 0.42 0.59 83.22 70.53 - LU0462856898 - -
A2 Hgd HKD Accumulating 195.87 1.13 0.58 231.14 192.28 - LU1061106388 - -
D4 USD Annual 14.60 0.09 0.62 17.05 14.33 - LU1728553774 - -
A2 Hgd CNH Accumulating 168.37 0.97 0.58 196.91 165.19 - LU1254117382 - -
C2 USD Accumulating 44.17 0.25 0.57 52.31 43.37 - LU0147404148 - -
I2 USD - 13.21 0.07 0.53 15.39 12.97 - LU1960219225 - -
A2 Hgd AUD Accumulating 19.03 0.11 0.58 22.55 18.69 - LU1023059063 - -
Class X10 USD - 9.40 0.01 0.11 10.46 9.27 - LU2471418801 - -
D2 EUR Accumulating 65.60 0.16 0.24 69.36 59.29 - LU0827889485 - -
A2 Hgd SGD Accumulating 19.47 0.11 0.57 22.92 19.11 - LU1057294990 - -
I2 EUR - 13.52 0.03 0.22 14.29 12.19 - LU1960219571 - -
A2 Hgd JPY Accumulating 1,215.00 7.00 0.58 1,446.00 1,193.00 - LU1948809360 - -
C2 EUR Accumulating 45.19 0.10 0.22 47.89 41.40 - LU0331289677 - -
D2 USD Accumulating 64.12 0.37 0.58 74.79 62.94 - LU0329593007 - -
A2 USD Accumulating 57.29 0.33 0.58 67.21 56.24 - LU0122379950 - -
A2 Hgd EUR Accumulating 12.81 0.07 0.55 15.30 12.58 - LU1822774284 - -
E2 EUR Accumulating 52.71 0.12 0.23 55.81 48.07 - LU0171309270 - -
Class AI2 EUR - 15.60 0.03 0.19 16.51 14.19 - LU1960224654 - -
E2 USD Accumulating 51.52 0.29 0.57 60.67 50.58 - LU0122380701 - -

Listings

Portfolio Managers

Portfolio Managers

Erin Xie
Head of Health Sciences Investing, Active Equities

Erin Xie, PhD, Managing Director and portfolio manager, is the head of the Health Sciences team, part of BlackRock's Active Equity Group.

Jeff Lee
Jeff Lee
Xiang Liu
Xiang Liu

Literature

Literature